CPA
VNRX icon

Cowen Prime Advisors’s VolitionRx Ltd VNRX Stock Holding History

Cowen Prime Advisors’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$248K Sell
8,937
-155
-2% -$5.1K 0.09% 78
2023
Q1 		$309K Buy
9,092
+240
+3% +$10K 0.12% 71
2022
Q4 		$430K Buy
8,852
+4,020
+83% +$156K 0.18% 60
2022
Q3 		$131K Buy
4,832
+1,042
+27% +$39.4K 0.08% 83
2022
Q2 		$155K Buy
3,790
+50
+1% +$2.52K 0.09% 84
2022
Q1 		$225K Buy
3,740
+510
+16% +$28.9K 0.09% 82
2021
Q4 		$203K Buy
3,230
+120
+4% +$8.19K 0.07% 82
2021
Q3 		$193K Buy
3,110
+150
+5% +$9.5K 0.07% 83
2021
Q2 		$195K Buy
2,960
+1,125
+61% +$76.1K 0.07% 79
2021
Q1 		$139K Buy
+1,835
New +$157K 0.05% 92
2020
Q3 		– Sell
-3,790
Closed -$155K – 196
2020
Q2 		$155K Buy
3,790
+3,739
+7,331% +$270K 0.09% 84
2020
Q1 		$3K Hold
51
– – ﹤0.01% 182
2019
Q4 		$5K Buy
+51
New +$5.29K ﹤0.01% 163
2019
Q1 		– Sell
-51
Closed -$2K – 188
2018
Q4 		$2K Buy
+51
New +$2.43K ﹤0.01% 172
2018
Q3 		– Sell
-141
Closed -$6K – 209
2018
Q2 		$6K Buy
+141
New +$6.3K ﹤0.01% 187

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAMC
Spectrum Asset Management (California) Newport Beach, California $315M AUM 19.93% 1-Year Est. Return
DI
DFPG Investments Sandy, Utah $1.28B AUM 27.55% 1-Year Est. Return

Cowen Prime Advisors's VNRX Position: Q2 2023 in Review

Cowen Prime Advisors reduced its VolitionRx Ltd (VNRX) stake by 1.7% in Q2 2023, selling an estimated $5.1K and leaving 8,937 shares worth $248K. The position accounts for 0.09% of the portfolio, ranked #78.

Cowen Prime Advisors first reported a position in VNRX in Q2 2018 and has held it in 15 quarters since. The position peaked at $430K in Q4 2022. 34 funds tracked by Wall St. Rank hold VNRX as of Q2 2023.

  • Cowen Prime Advisors held 8,937 shares of VolitionRx Ltd worth $248K as of Q2 2023.
  • Cowen Prime Advisors sold 155 VolitionRx Ltd shares in Q2 2023, an estimated $5.1K.
  • VolitionRx Ltd made up 0.09% of Cowen Prime Advisors's portfolio in Q2 2023, its #78 holding.
  • Cowen Prime Advisors first reported a position in VolitionRx Ltd in Q2 2018 and has held it in 15 quarters since.
  • Cowen Prime Advisors's VolitionRx Ltd position peaked at $430K in Q4 2022.
  • 34 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2023.

Based on Cowen Prime Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.